HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
Karen Schreiber(Guy's and St Thomas' NHS Foundation Trust), Beverley J. Hunt(Guy's and St Thomas' NHS Foundation Trust), Susan Robinson(Guy's and St Thomas' NHS Foundation Trust), Dario Roccatello(5T Torino (Italy)), Savino Sciascia(Ospedale San Giovanni Bosco), Paul T. Seed(St Thomas' Hospital), Karen Breen(Guy's and St Thomas' NHS Foundation Trust), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Søren Jacobsen(University of Copenhagen), Linda Watkins(University of Liverpool), Saskia Middeldorp(Radboud University Nijmegen), Lesley Regan(St Mary's Hospital), Sue Pavord(NHS Blood and Transplant)
Cited by 125
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
|Critical Care|2016|1.5k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
|Critical Care|2019|1.3k
ESHRE guideline: recurrent pregnancy loss
|Human Reproduction Open|2018|993